Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrhythmia

Department of Nutrition, Harvard University School, Boston, Massachusetts.

Day to day variability of ventricular ectopic activity was analyzed in 45 patients with a history of malignant ventricular tachyarrhythmias who underwent two successive 24 h periods of ambulatory electrocardiographic (ECG) monitoring in the absence of antiarrhythmic drugs; 26 were male and 19 female, with a mean age of 56 years (range 15 to 76). The total number of single ventricular premature beats, couplets and ventricular tachycardia beats and runs on days 1 and 2 demonstrated a consistent overall correlation (r = 0.76 to 0.84). Individual variability was evaluated by regression analysis with determination of 95% confidence limits. The minimal decrease in arrhythmia density necessary to distinguish true drug effect from spontaneous variability was 64% for single ventricular premature beats, 83% for couplets, 90% for ventricular tachycardia runs and 93% for ventricular tachycardia beats. To meet the criteria for arrhythmia aggravation, the arrhythmia density had to increase by 400, 877, 1,500 and 2,400%, respectively. Multivariate analysis disclosed an inverse relation between day to day arrhythmia variability and baseline arrhythmia density and age. Variability was more pronounced in patients with coronary artery disease but was not influenced by the type of presenting arrhythmia or left ventricular function. The diurnal distribution of arrhythmias and heart rate followed a distinct circadian pattern. These data indicate that, despite good group reproducibility, spontaneous arrhythmia variability in individuals is substantial, necessitating standards to define both drug effect and arrhythmia aggravation.

This article has been cited by other articles:

				K.-M. Yee, S. D. Pringle, and A. D. Struthers Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1800 - 1807. [Abstract] [Full Text] [PDF]

				E. Yetkin, K. Senen, M. Ileri, R. Atak, S. Topaloglu, K. Ergun, A. Yanik, I. Tandogan, S. Cehreli, E. Duru, et al. Diurnal Variation of QT Dispersion in Patients With and Without Coronary Artery Disease Angiology, May 1, 2001; 52(5): 311 - 316. [Abstract] [PDF]

				M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF]

				R. W. Peters, S. McQuillan, S. K. Resnick, and M. R. Gold Increased Monday Incidence of Life-Threatening Ventricular Arrhythmias: Experience With a Third-Generation Implantable Defibrillator Circulation, September 15, 1996; 94(6): 1346 - 1349. [Abstract] [Full Text]

				T. Q. Kong Jr, J. J. Goldberger, M. Parker, T. Wang, and A. H. Kadish Circadian Variation in Human Ventricular Refractoriness Circulation, September 15, 1995; 92(6): 1507 - 1516. [Abstract] [Full Text]

				G. H. Tofler, O. C. E. Gebara, M. A. Mittleman, P. Taylor, W. Siegel, F. J. Venditti Jr, C. A. Rasmussen, J. E. Muller, and f. t. C. Investigators Morning Peak in Ventricular Tachyarrhythmias Detected by Time of Implantable Cardioverter/Defibrillator Therapy Circulation, September 1, 1995; 92(5): 1203 - 1208. [Abstract] [Full Text]